Telix Pharmaceuticals Ltd — Share Issue/Capital Change 2023

May 4, 2023

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

TELIX PHARMACEUTICALS LIMITED

Date of this announcement

Friday May 05, 2023

The +securities the subject of this notification are:

==> picture [8 x 9] intentionally omitted <==

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

		Total number of
ASX +security		+securities to be
code	Security description	issued/transferred	Issue date
TLXAO	SHARE APPRECIATION RIGHTS	3,114,390	02/05/2023

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

1 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

TELIX PHARMACEUTICALS LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2 Registered number type

ACN

Registration number

616620369

1.3 ASX issuer code

TLX

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

5/5/2023

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

2 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

==> picture [21 x 22] intentionally omitted <==

2.1 The +securities the subject of this notification are:

==> picture [8 x 8] intentionally omitted <==

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

==> picture [8 x 8] intentionally omitted <==

has an existing ASX security code ("existing class")

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

3 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B

ASX +security code and description

TLXAO : SHARE APPRECIATION RIGHTS

Date the +securities the subject of this notification were issued

2/5/2023

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class

==> picture [9 x 8] intentionally omitted <==

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate? Yes

Provide details of the KMP or +associates being issued +securities.

Name of KMP	Name of registered holder	Number of +securities
Darren Smith	Darren Smith	70,798
Colin Hayward	Colin Hayward	79,336
Richard Valeix	Richard Valeix	81,214

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

• Refer to Telix's 2022 Remuneration Report, within the 2022 Annual Report, accessible at https://telixpharma.com/investor centre/financial-reports-presentations/ and to Telix's 2023 Annual General Meeting Notice of Meeting for Performance Share Appreciation Rights valuation methodology, accessible at https://telixpharma.com/news-views/notice-of-annual-gen eral-meeting-2023/

Any other information the entity wishes to provide about the +securities the subject of this notification

Performance Share Appreciation Rights granted to Telix management as part of Target Total Remuneration Package for FY23. Vesting is subject to achievement of performance conditions and the terms of the equity incentive plan rules, with a measurement period of FY23-FY25. For further details, refer to the Remuneration Report in Telix's 2022 Annual Report.

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

4 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Issue details

==> picture [21 x 22] intentionally omitted <==

Number of +securities

3,114,390

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

5 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - +Securities on issue

Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +Securities (Total number of each +class of +securities quoted)

	Total number of
ASX +security code and description	+securities on issue
TLX : ORDINARY FULLY PAID	318,358,289

4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
TLXAJ : OPTION EXPIRING 30-JUN-2024 EX $1.83	1,300,000
TLXAI : OPTION EXPIRING 12-JAN-2024 EX $2.23	1,585,000
TLXAQ : SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL	80,000
TLXAG : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	250,000
TLXAP : SHARE RIGHTS	100,000
TLXAO : SHARE APPRECIATION RIGHTS	6,790,030
TLXAH : OPTION EXPIRING 03-NOV-2023 EX $2.30	100,000
TLXAM : OPTION EXPIRING 20-JUL-2026 EX $5.37	827,992
TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL	100,000
TLXAL : OPTION EXPIRING 27-JAN-2026 EX $4.38	1,145,008

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

6 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? Yes

5.1a Select the number of the applicable exception in Listing Rule 7.2

13

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

7 / 7